Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

The novel role of resveratrol in attenuating cisplatin induced testicular toxicity in rats.

View through CrossRef
Objectives: To evaluate the anti-oxidative role of Resveratrol in Cisplatin-induced testicular toxicity in Albino Wistar rats. Study Design: Quasi-experimental study. Settings: Department of Physiology and Postgraduate Laboratory of ISRA University Hyderabad. Period: Six months from March to September 2019. Material & Methods: Twenty-four male albino Wistar rats were distributed equally into; Group-I (Control), Group-II (Cisplatin), Group-III (Cisplatin + Resveratrol). Difference in mean pre and post-experimental body weight was observed while analysis of oxidative markers, semen parameters, and histomorphology was carried out in all three groups. SPSS ver. 22 was used to analyze the data. Results: The mean body weight decreased from 241.7±8.5 gm to 196.50±9.34 gm and from 237±7.4 gm to 210.0 ± 6.50gm in groups II and III respectively. Statistically significant reduction in semen parameters (sperm count, motility and viability) was observed in Group-II compared with Group-C (p<0.05). Oxidative markers were also significantly depleted in Group-II in comparison to Group-C (p<0.05). Histologically, testicular structure was found to be intact in Group-I. Marked changes were observed in testicular histology of Group-II while Group-III displayed less testicular damage. Irregular, regressive and atrophic seminiferous tubules were seen in Group-II. Most seminiferous tubules having normal morphology were observed in Group-III while the number of atrophic and degenerative seminiferous tubules also decreased significantly. Conclusion: Resveratrol therapy is a potent protective regime showing promising results in cisplatin-induced testicular toxicity and oxidative stress.
Title: The novel role of resveratrol in attenuating cisplatin induced testicular toxicity in rats.
Description:
Objectives: To evaluate the anti-oxidative role of Resveratrol in Cisplatin-induced testicular toxicity in Albino Wistar rats.
Study Design: Quasi-experimental study.
Settings: Department of Physiology and Postgraduate Laboratory of ISRA University Hyderabad.
Period: Six months from March to September 2019.
Material & Methods: Twenty-four male albino Wistar rats were distributed equally into; Group-I (Control), Group-II (Cisplatin), Group-III (Cisplatin + Resveratrol).
Difference in mean pre and post-experimental body weight was observed while analysis of oxidative markers, semen parameters, and histomorphology was carried out in all three groups.
SPSS ver.
22 was used to analyze the data.
Results: The mean body weight decreased from 241.
7±8.
5 gm to 196.
50±9.
34 gm and from 237±7.
4 gm to 210.
0 ± 6.
50gm in groups II and III respectively.
Statistically significant reduction in semen parameters (sperm count, motility and viability) was observed in Group-II compared with Group-C (p<0.
05).
Oxidative markers were also significantly depleted in Group-II in comparison to Group-C (p<0.
05).
Histologically, testicular structure was found to be intact in Group-I.
Marked changes were observed in testicular histology of Group-II while Group-III displayed less testicular damage.
Irregular, regressive and atrophic seminiferous tubules were seen in Group-II.
Most seminiferous tubules having normal morphology were observed in Group-III while the number of atrophic and degenerative seminiferous tubules also decreased significantly.
Conclusion: Resveratrol therapy is a potent protective regime showing promising results in cisplatin-induced testicular toxicity and oxidative stress.

Related Results

Abstract 1761: Dual inhibition of HSP27 and FAO as a novel therapeutic strategy for cisplatin-resistant ovarian cancer
Abstract 1761: Dual inhibition of HSP27 and FAO as a novel therapeutic strategy for cisplatin-resistant ovarian cancer
Abstract Cisplatin is the most commonly employed chemotherapeutic drug for ovarian cancer treatment. However, most ovarian cancer patients experience recurrent cispl...
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
RAD51C is a RAD51 paralog protein that mediates RAD51 filament formation on single-stranded DNA (ssDNA) in a canonical homologous recombination (HR) pathway. This step is vital for...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
&lt;p&gt;&lt;strong&gt;&lt;span dir=&quot;ltr&quot; role=&quot;presentation&quot;&gt;1. Introduction&lt;/span&gt;&lt;/strong&...
Prenatal DEHP exposure induces lifelong testicular toxicity by continuously interfering with steroidogenic gene expression
Prenatal DEHP exposure induces lifelong testicular toxicity by continuously interfering with steroidogenic gene expression
Abstract Epidemiologic studiessuggested the association between prenatal Di-(2-ethylhexyl) phthalate (DEHP) exposure and disorders of sex development (DSD), adult male diso...
Resveratrol mitigates diclofenac‐induced hepatorenal toxicity in rats via modulation of miR‐144/Nrf2/GSH axis
Resveratrol mitigates diclofenac‐induced hepatorenal toxicity in rats via modulation of miR‐144/Nrf2/GSH axis
AbstractDespite the extensive therapeutic uses of diclofenac, it may cause several adverse effects, including hepatorenal injury. The antioxidant and anti‐inflammatory properties o...
The Testicular Protection Effect of Thiamine Pyrophosphate Against Cisplatin-treated Male Rats
The Testicular Protection Effect of Thiamine Pyrophosphate Against Cisplatin-treated Male Rats
Infertility is a worldwide problem affecting both genders, it can be defined as the inability of the adult males to make a fertile woman pregnant after one year of regular intercou...

Back to Top